Combination therapy with VPA and BM-MSC-TK synergistically induced apoptosis in glioma cells by caspase activation in vitro and also potently suppressed tumor development and extended the survival of glioma-bearing mice (Ryu et al., 2012). This evidence concerns the gene TKT and central nervous system cancer.